Systemic Light Chain Amyloidosis
📧 Sign up to get email alerts when something new happens for Systemic Light Chain Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis [Phase 3]
A Phase 3 trial evaluating dexamethasone plus ixazomib versus physician's choice in relapsed or refractory systemic light chain (AL) amyloid…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis [Phase 1]
A completed Phase 1 safety study assessing carfilzomib in patients with previously treated systemic light-chain amyloidosis.
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis [Phase 3]
Phase 3 trial evaluating melphalan and dexamethasone with or without bortezomib in previously untreated systemic light-chain amyloidosis (pr…